Stay updated on SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.

Latest updates to the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo significant additions or deletions were detected in the study details page; changes appear to be routine data updates or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedReplace Sage Therapeutics with Supernus Pharmaceuticals, Inc. and update date references to 2025-10-01 and 2025-10-14, with an “Last Update Posted (Estimated)” marker. Interpreted as a branding/ownership or documentation update rather than substantive content changes.SummaryDifference1%

- Check38 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check45 days agoChange DetectedThe page update adds a new version tag (v3.1.0) and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2), indicating a cleanup of outdated topics rather than adding new core content.SummaryDifference0.4%

- Check60 days agoChange DetectedUpdated to v3.0.2 and removed the Back to Top element; no core content or critical information is affected.SummaryDifference0.1%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

Stay in the know with updates to SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.